COM:GENSIGHT-BIOLOGICS
GenSight Biologics S.A.
- Stock
Last Close
0.32
25/11 08:59
Market Cap
31.04M
Beta: -
Volume Today
88.55K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 4.42M - | 4.42M 0% | ||||||||||
average payables | 750.76K - | 1.64M 118.69% | 3.55M 116.28% | 3.46M 2.47% | 1.98M 42.84% | 4.91M 147.99% | 7.37M 50.05% | 7.36M 0.03% | 9.57M 30.03% | 9.69M 1.17% | ||
average receivables | 1K - | 1K 0% | ||||||||||
book value per share | 1.25 - | 0.78 37.64% | 2.61 235.65% | 3.28 25.78% | 2.51 23.61% | 0.98 61.09% | 0.41 57.58% | 0.33 19.74% | 0.35 6.63% | -0.33 193.12% | ||
capex per share | -0.03 - | -0.01 44.82% | -0.06 352.56% | -0.01 81.49% | -0.01 7.59% | -0.03 200.50% | -0.00 91.72% | -0.00 93.62% | -0.00 314.93% | -0.01 667.45% | ||
capex to depreciation | -8.50 - | -0.74 91.30% | -5.10 589.07% | -0.93 81.69% | -1.05 12.87% | -2.51 138.34% | -0.08 96.93% | -0.01 91.60% | -0.03 432.18% | -0.24 588.78% | ||
capex to operating cash flow | 0.18 - | 0.03 80.49% | 0.06 70.48% | 0.01 83.52% | 0.01 30.43% | 0.03 121.79% | 0.00 90.30% | 0.00 85.25% | 0.00 368.14% | 0.01 299.87% | ||
capex to revenue | -0.11 - | -0.00 98.74% | -0.01 344.17% | -0.10 1,509.16% | ||||||||
cash per share | 1.26 - | 0.89 29.38% | 2.67 201.51% | 3.32 24.19% | 2.53 23.90% | 1.07 57.57% | 0.68 36.76% | 1.08 59.26% | 0.98 9.19% | 0.23 76.65% | ||
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | ||||||||||||
debt to assets | 0.04 - | 0.02 59.85% | 0.05 187.94% | 0.05 1.19% | 0.09 90.87% | 0.24 162.92% | 0.31 24.71% | 0.22 27.29% | 0.49 119.78% | |||
debt to equity | 0.06 - | 0.02 64.51% | 0.05 158.24% | 0.06 0.66% | 0.14 161.39% | 0.68 369.33% | 1.24 83.06% | 0.79 36.55% | -0.83 205.33% | |||
dividend yield | 0.01 - | |||||||||||
earnings yield | -0.02 - | -0.06 141.46% | -0.15 147.81% | -0.18 17.62% | -0.18 1.79% | -0.41 130.10% | -0.44 6.04% | -0.14 68.81% | -0.11 16.07% | -0.18 55.57% | -1.18 564.92% | |
enterprise value | 93.82M - | 100.88M 7.52% | 62.17M 38.38% | 74.90M 20.48% | 82.71M 10.43% | 58.67M 29.06% | 59.23M 0.94% | 226.96M 283.21% | 219.32M 3.37% | 157.80M 28.05% | ||
enterprise value over ebitda | -32.65 - | -15.33 53.04% | -4.58 70.10% | -3.44 25.00% | -3.47 1.06% | -1.79 48.39% | -2.02 12.63% | -9.45 368.12% | -8.17 13.52% | -5.97 27.00% | ||
ev to operating cash flow | -48.11 - | -18.29 61.99% | -5.14 71.89% | -3.81 25.81% | -4.40 15.48% | -2.07 53.06% | -2.11 1.92% | -15.09 616.08% | -12.80 15.18% | -4.68 63.46% | ||
ev to sales | 84.61 - | 51.65 38.95% | 41.57 19.52% | 61.12 47.02% | ||||||||
free cash flow per share | -0.17 - | -0.42 148.84% | -1.14 171.67% | -1.22 7.13% | -0.87 28.95% | -1.19 37.54% | -0.99 16.71% | -0.43 56.86% | -0.38 11.24% | -0.73 92.99% | ||
free cash flow yield | -0.02 - | -0.05 148.84% | -0.14 171.67% | -0.16 12.66% | -0.14 10.61% | -0.36 154.42% | -0.40 11.61% | -0.06 84.96% | -0.07 13.83% | -0.22 219.17% | ||
graham net net | 1.12 - | 0.58 48.42% | 2.05 256.65% | 2.96 44.12% | 2.20 25.69% | 0.72 67.37% | -0.05 107.30% | 0.06 222.20% | 0.08 25.57% | -0.66 921.78% | ||
graham number | 2.39 - | 2.93 22.70% | 8.44 188.41% | 10.02 18.61% | 7.87 21.38% | 5.48 30.43% | 3.17 42.06% | 2.69 15.25% | 2.25 16.46% | 2.10 6.40% | ||
income quality | 0.71 - | 0.83 17.15% | 0.89 7.12% | 0.89 0.42% | 0.78 12.43% | 0.85 8.92% | 0.92 7.89% | 0.44 51.69% | 0.60 35.42% | 1.22 104.01% | ||
intangibles to total assets | 0.01 - | 0.02 18.05% | 0.01 61.73% | 0.00 44.57% | 0.00 13.47% | 0.00 52.78% | 0.00 4.35% | 0.00 40.77% | 0.00 29.60% | 0.00 81.33% | 0 100% | |
interest coverage | 37.59 - | 93.62 149.09% | 1.78K 1,801.74% | -246.11 113.82% | -315.66 28.26% | -80.99 74.34% | -78.09 3.59% | -14.52 81.40% | -12.99 10.58% | -10.50 19.11% | ||
interest debt per share | -0.01 - | 0.04 841.96% | 0.05 32.80% | 0.19 238.95% | 0.14 23.52% | 0.16 11.00% | 0.29 86.67% | 0.46 56.72% | 0.33 29.11% | 0.33 1.19% | ||
inventory turnover | ||||||||||||
invested capital | 0.06 - | 0.02 64.51% | 0.05 158.24% | 0.06 0.66% | 0.14 161.39% | 0.68 369.33% | 1.24 83.06% | 0.79 36.55% | -0.83 205.33% | |||
market cap | 110.91M - | 110.91M 0.00% | 91.60M 17.41% | 125.96M 37.50% | 135.13M 7.28% | 81.47M 39.71% | 70.53M 13.43% | 250.45M 255.10% | 251.04M 0.23% | 155.76M 37.95% | 22.22M 85.74% | |
net current asset value | 16.35M - | 10.03M 38.66% | 28.13M 180.46% | 52.18M 85.48% | 53.59M 2.72% | 21.98M 59.00% | 7.03M 68.02% | 8.06M 14.76% | 12.71M 57.53% | -18.27M 243.83% | ||
net debt to ebitda | 5.95 - | 1.53 74.36% | 2.17 42.29% | 2.34 7.97% | 2.20 6.06% | 0.70 68.36% | 0.39 44.68% | 0.98 153.91% | 1.18 20.85% | -0.08 106.52% | ||
net income per share | -0.20 - | -0.49 141.46% | -1.21 147.81% | -1.36 11.84% | -1.10 19.10% | -1.37 24.39% | -1.08 20.86% | -0.97 10.50% | -0.63 34.55% | -0.60 5.93% | -0.54 9.02% | |
operating cash flow per share | -0.14 - | -0.41 182.88% | -1.08 165.47% | -1.21 12.31% | -0.86 29.15% | -1.16 35.49% | -0.99 14.62% | -0.43 56.76% | -0.38 11.37% | -0.73 91.92% | ||
payables turnover | ||||||||||||
receivables turnover | ||||||||||||
research and ddevelopement to revenue | 40.22 - | 5.00 87.56% | 4.27 14.58% | 7.33 71.58% | 7.03 4.11% | |||||||
return on tangible assets | -0.15 - | -0.46 208.32% | -0.38 17.33% | -0.37 1.13% | -0.39 3.91% | -0.91 133.78% | -0.95 4.53% | -0.72 24.18% | -0.51 29.72% | -1.07 111.14% | ||
revenue per share | 0.02 - | 0.13 407.19% | 0.12 6.58% | 0.06 52.31% | 0.06 11.45% | |||||||
roe | -0.16 - | -0.63 287.22% | -0.47 26.17% | -0.41 11.08% | -0.44 5.91% | -1.40 219.65% | -2.61 86.56% | -2.92 11.52% | -1.79 38.62% | 1.81 201.02% | ||
roic | -0.16 - | -0.59 270.92% | -0.45 22.51% | -0.39 13.65% | -0.41 5.35% | -1.22 196.22% | -1.32 7.49% | -0.87 34.05% | -0.91 5.18% | 36.34 4,080.12% | ||
sales general and administrative to revenue | 3.93 - | 0.68 82.74% | 1.08 58.69% | 3.10 188.02% | ||||||||
shareholders equity per share | 1.25 - | 0.78 37.64% | 2.61 235.65% | 3.28 25.78% | 2.51 23.61% | 0.98 61.09% | 0.41 57.58% | 0.33 19.74% | 0.35 6.63% | -0.33 193.12% | ||
stock based compensation to revenue | 1.87 - | 0.79 57.89% | 0.92 16.52% | -1.30 242.20% | ||||||||
tangible asset value | 16.71M - | 10.34M 38.11% | 29.10M 181.47% | 53.14M 82.59% | 54.81M 3.15% | 23.70M 56.76% | 11.59M 51.09% | 11.53M 0.50% | 15.88M 37.66% | -15.37M 196.81% | ||
tangible book value per share | 1.23 - | 0.76 38.11% | 2.59 240.81% | 3.27 26.27% | 2.50 23.57% | 0.97 61.23% | 0.41 57.84% | 0.33 19.60% | 0.35 7.10% | -0.33 194.35% | ||
working capital | 16.36M - | 10.70M 34.58% | 28.82M 169.28% | 55.17M 91.43% | 56.72M 2.80% | 25.48M 55.07% | 17.26M 32.27% | 26.64M 54.33% | 31.12M 16.84% | 8.30M 73.31% |
All numbers in EUR (except ratios and percentages)